Using Bupivacaine Locally in the Mastectomy Drains to Control Postoperative Pain

NCT03799757 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 168

Last updated 2019-01-10

No results posted yet for this study

Summary

in this study we are investigating the role of instillation of Bupivacaine through surgical drains at the end of mastectomy surgeries in controlling post operative pain and decreasing their pain killers requirement in the early postoperative period

Conditions

Interventions

DRUG

40ml of 0.25% bupivacaine

DRUG

40ml of 0.9% normal saline

Sponsors & Collaborators

  • Alexandria University

    lead OTHER

Principal Investigators

  • Mahmoud A Alhussini, md · faculty of medicine , univeristy of alexandria

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-01-31
Primary Completion
2018-11-30
Completion
2018-12-31

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03799757 on ClinicalTrials.gov